Sort   by:  
 Page size 
ProteomicsHOXB13 WT and G84E mass spectrometry
To identify potential cofactors of HOXB13 in suppressing lipogenic programs in prostate cancer cells, we performed tandem affinity purification followed by mass spectrometry analysis of WT and G84E HOXB13 expressed in LNCaP cells. Out of the HOXB13-enriched proteins are previously reported interacto...
ORGANISM(S): Homo sapiens (Human) 
2023-03-11 | PXD030810 | Pride
Prostate cancer Tandem affinity purification Hoxb13 
UnknownFOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A.
Not available
S-EPMC9464719 | biostudies-literature
TranscriptomicsAn Integrated Network of Androgen Receptor and TMPRSS2-ERG Gene Fusion in Prostate Cancer Progression
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Homo sapiens 
2010-05-18 | E-GEOD-14097 | biostudies-arrayexpress
TranscriptomicsAn Integrated Network of Androgen Receptor and TMPRSS2-ERG Gene Fusion in Prostate Cancer Progression (II)
Androgen receptor (AR) is a transcription factor that plays a central role in the growth and development of the normal prostate and its malignant transformation. More recently, a majority of prostate cancers have been shown to harbor recurrent gene fusions of the androgen-regulated gene, TMPRSS2, t...
ORGANISM(S): Homo sapiens 
2010-05-17 | E-GEOD-14092 | biostudies-arrayexpress
ProteomicsIdentify FOXA2-interacting proteins in NEPC cells
Following extensive treatment with androgen receptor (AR) pathway inhibitors, a significant number of metastatic prostate cancer develop treatment resistance, and approximately 20% of these castration-resistant prostate cancers (CRPC) transdifferentiate, at least partially, into neuroendocrine (NE) ...
ORGANISM(S): Homo sapiens (Human) 
2025-06-12 | PXD061080 | Pride
Nepc Foxa2 
ProteomicsIdentify FOXA2-interacting proteins in NEPC cells
Following extensive treatment with androgen receptor (AR) pathway inhibitors, a significant number of metastatic prostate cancer develop treatment resistance, and approximately 20% of these castration-resistant prostate cancers (CRPC) transdifferentiate, at least partially, into neuroendocrine (NE) ...
ORGANISM(S): Homo sapiens (Human) 
2025-06-12 | PXD061127 | Pride
Nepc Foxa2 
UnknownHOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.
Not available
S-EPMC9117466 | biostudies-literature
UnknownPosttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer.
Not available
S-EPMC8026124 | biostudies-literature
ProteomicsGuinea pig myopia model ocular posterior pole
Proteomic analyses of the ocular posterior pole tissues at 6 weeks after induction of form-deprived myopia and lens-induced myopia models in guinea pigs.
ORGANISM(S): Cavia Porcellus 
2022-11-01 | PXD037872 |
Sort   by:  
 Page size